Munafa Stock Market Course + Intraday & FNO calls 
Theravance Biopharma (TBPH) Technical (Analysis) Reports Theravance Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Theravance Biopharma (TBPH)
Technical Analysis Report for USA stock TBPH Theravance Biopharma. Dated: 21 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock TBPH Theravance Biopharma then click here. or read Experts views on Theravance Biopharma or Forecast & share price targets of Theravance Biopharma
Theravance Biopharma Opened at 20.40 and Closed at: 20.37, which is -0.25% of previous session's close. It moved within a range of 19.99 and 20.43
The session was a Bearish session with an average volume of 360000, which is 17.11% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 19.96 and resistance for tomorrow is 20.4
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 20.1, 19.82 resistance for tomorrow's hourly charts is 20.54, 20.7
10 Day SMA for Theravance Biopharma (TBPH) is 19.84 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Theravance Biopharma (TBPH) is 19.23 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Theravance Biopharma (TBPH) is 18.56 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 16.37 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Theravance Biopharma is 13.5 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Theravance Biopharma is at 19.23 and 200 DMA is at 13.5, while 50 DMA and 100 DMA are at 18.56 and 16.37 respectively
Theravance Biopharma (TBPH) moving average of 20 SMA is at 19.23 and 20 EMA is at 19.38
| Date | Closing Price | 20 SMA | 20 EMA |
| 21 Wed Jan | 20.37 | 19.23 | 19.38 |
| 20 Tue Jan | 20.42 | 19.15 | 19.28 |
| 16 Fri Jan | 20.01 | 19.04 | 19.16 |
| 15 Thu Jan | 20.11 | 18.93 | 19.07 |
| 14 Wed Jan | 20.61 | 18.8 | 18.96 |
| 13 Tue Jan | 20.33 | 18.66 | 18.79 |
Theravance Biopharma (TBPH) moving average of 50 SMA is at 18.56 and 50 EMA is at 18.28
| Date | Closing Price | 50 SMA | 50 EMA |
| 21 Wed Jan | 20.37 | 18.56 | 18.28 |
| 20 Tue Jan | 20.42 | 18.45 | 18.19 |
| 16 Fri Jan | 20.01 | 18.34 | 18.1 |
| 15 Thu Jan | 20.11 | 18.24 | 18.02 |
| 14 Wed Jan | 20.61 | 18.13 | 17.93 |
| 13 Tue Jan | 20.33 | 18.01 | 17.82 |
Theravance Biopharma (TBPH) moving average of 100 SMA is at 16.37 and 100 EMA is at 16.68
| Date | Closing Price | 100 SMA | 100 EMA |
| 21 Wed Jan | 20.37 | 16.37 | 16.68 |
| 20 Tue Jan | 20.42 | 16.3 | 16.61 |
| 16 Fri Jan | 20.01 | 16.24 | 16.53 |
| 15 Thu Jan | 20.11 | 16.18 | 16.46 |
| 14 Wed Jan | 20.61 | 16.11 | 16.39 |
| 13 Tue Jan | 20.33 | 16.05 | 16.3 |
Theravance Biopharma (TBPH) moving average of 200 SMA is at 13.5 and 200 EMA is at 14.54
| Date | Closing Price | 200 SMA | 200 EMA |
| 21 Wed Jan | 20.37 | 13.5 | 14.54 |
| 20 Tue Jan | 20.42 | 13.44 | 14.48 |
| 16 Fri Jan | 20.01 | 13.38 | 14.42 |
| 15 Thu Jan | 20.11 | 13.32 | 14.36 |
| 14 Wed Jan | 20.61 | 13.26 | 14.3 |
| 13 Tue Jan | 20.33 | 13.21 | 14.24 |
Theravance Biopharma has performed better than Haemonetics Corporation in short term. Holding Theravance Biopharma could be a better choice for now!
Theravance Biopharma has performed better than Abbott Laboratories in short term. Holding Theravance Biopharma could be a better choice for now!
Veru Inc has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Veru Inc, about 4.81% more returns!
Theravance Biopharma has performed better than Tonix Pharmaceuticals in short term. Holding Theravance Biopharma could be a better choice for now!
Theravance Biopharma has performed better than Siga Technologies in short term. Holding Theravance Biopharma could be a better choice for now!
Theravance Biopharma has performed better than Sangamo Therapeutics in short term. Holding Theravance Biopharma could be a better choice for now!
Theravance Biopharma has performed better than Nucana Plc in short term. Holding Theravance Biopharma could be a better choice for now!
Theravance Biopharma has performed better than Neurocrine Biosciences in short term. Holding Theravance Biopharma could be a better choice for now!
Theravance Biopharma has performed better than Merit Medical in short term. Holding Theravance Biopharma could be a better choice for now!
Moleculin Biotech has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Moleculin Biotech, about 9.12% more returns!
Liquidia Technologies has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Liquidia Technologies, about 3.48% more returns!
Theravance Biopharma has performed better than Iradimed Corporation in short term. Holding Theravance Biopharma could be a better choice for now!
Theravance Biopharma has performed better than Icu Medical in short term. Holding Theravance Biopharma could be a better choice for now!
Immucell Corporation has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Immucell Corporation, about 6.96% more returns!
Theravance Biopharma has performed better than Exact Sciences in short term. Holding Theravance Biopharma could be a better choice for now!
Cue Biopharma has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Cue Biopharma, about 43.71% more returns!
Aclaris Therapeutics has performed better than Theravance Biopharma in short term. You could have earned much better returns by investing in Aclaris Therapeutics, about 35.54% more returns!
Theravance Biopharma Technical analysis of indicators
Price action analysis of Theravance Biopharma (TBPH) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Theravance Biopharma stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Theravance Biopharma in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Theravance Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Theravance Biopharma in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Theravance Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 19.77 and Theravance Biopharma TBPH stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Theravance Biopharma TBPH stock. Volume based technical analysis of Theravance Biopharma TBPH stock is negative.
Theravance Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock TBPH Theravance Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And TBPH Experts View which covers a lot of information including buying and selling signals
TBPH future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Theravance Biopharma or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Theravance Biopharma (TBPH) Technical (Analysis) Reports Theravance Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
